Literature DB >> 22355052

Is adjuvant chemotherapy useful for women with luminal a breast cancer?

Alan S Coates1, Marco Colleoni, Aron Goldhirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22355052     DOI： 10.1200/JCO.2011.37.7879

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

Review 1.  High-risk estrogen-receptor-positive breast cancer: identification and implications for therapy.

Authors:  Rosemary L Balleine; Nicholas R Wilcken
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

2.  Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified.

Authors:  Wei Zhang; Tongxian Zhang; Zhichun Lin; Xuebao Zhang; Fen Liu; Yahong Wang; Han Liu; Yiling Yang; Yun Niu
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

3.  Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.

Authors:  Richard R Love; Adriano V Laudico; Nguyen Van Dinh; D Craig Allred; Gemma B Uy; Le Hong Quang; Jonathan Disraeli S Salvador; Stephen Sixto S Siguan; Maria Rica Mirasol-Lumague; Nguyen Dinh Tung; Noureddine Benjaafar; Narciso S Navarro; Tran Tu Quy; Arturo S De La Peña; Rodney B Dofitas; Orlino C Bisquera; Nguyen Dieu Linh; Ta Van To; Gregory S Young; Erinn M Hade; David Jarjoura
Journal:  J Natl Cancer Inst       Date:  2015-03-19       Impact factor: 13.506

4.  Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study.

Authors:  Joohyun Woo; Byung-In Moon; Hyungju Kwon; Woosung Lim
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

5.  Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes.

Authors:  Çetin Ordu; Kezban Nur Pilancı; Gül Alço; Filiz Elbüken; Ülkühan İner Köksal; Serkan İlgun; Dauren Sarsenov; Ayşe Esra Aydın; Alper Öztürk; Zeynep İyigün Erdoğan; Filiz Ağaçayak; Fatmagül Çubuk; Coşkun Tecimer; Yeşim Eralp; Tomris Duymaz; Fatma Aktepe; Vahit Özmen
Journal:  Eur J Breast Health       Date:  2018-07-01

6.  Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?

Authors: 
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

Review 7.  A pure invasive cribriform carcinoma of the breast with bone metastasis if untreated for thirteen years: a case report and literature review.

Authors:  Wei Zhang; Zhichun Lin; Tongxian Zhang; Fen Liu; Yun Niu
Journal:  World J Surg Oncol       Date:  2012-11-20       Impact factor: 2.754

8.  Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.

Authors:  Qian Li; Mei Liu; Fei Ma; Yang Luo; Ruigang Cai; Liming Wang; Ningzhi Xu; Binghe Xu
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

9.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976

Review 10.  "OMIC" tumor markers for breast cancer: A review.

Authors:  Naila Irum Hadi; Qamar Jamal
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.